PMC:7652766 / 107843-108068 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7652766","sourcedb":"PMC","sourceid":"7652766","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7652766","text":"Additionally, some patients, mainly in the high-dose group, showed adverse effects, such as increased creatine phosphokinase (CK) and CK-MB, while the high-dosage group exhibited more corrected QT (QTc) interval prolongation.","tracks":[{"project":"LitCovid-PD-HP","denotations":[{"id":"T156","span":{"begin":92,"end":124},"obj":"Phenotype"}],"attributes":[{"id":"A156","pred":"hp_id","subj":"T156","obj":"http://purl.obolibrary.org/obo/HP_0003236"},{"subj":"T156","pred":"source","obj":"LitCovid-PD-HP"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T530","span":{"begin":0,"end":225},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T530","pred":"source","obj":"LitCovid-sentences"}]},{"project":"LitCovid-PubTator","denotations":[{"id":"3988","span":{"begin":19,"end":27},"obj":"Species"},{"id":"3994","span":{"begin":102,"end":110},"obj":"Chemical"}],"attributes":[{"id":"A3988","pred":"tao:has_database_id","subj":"3988","obj":"Tax:9606"},{"id":"A3994","pred":"tao:has_database_id","subj":"3994","obj":"MESH:D003401"},{"subj":"3988","pred":"source","obj":"LitCovid-PubTator"},{"subj":"3994","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-HP","color":"#93ecd7","default":true},{"id":"LitCovid-sentences","color":"#ecbd93"},{"id":"LitCovid-PubTator","color":"#a293ec"}]}]}}